These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5936505)

  • 1. Bilirubin encephalopathy: experimental models in newborn and adult animals.
    Diamond I
    Proc Inst Med Chic; 1966 May; 26(3):47-8. PubMed ID: 5936505
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of bilirubin encephalopathy: experimental models in newborn and adult animals.
    Diamond I; Schmid R
    Trans Am Neurol Assoc; 1965; 90():38-41. PubMed ID: 5857773
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidative phosphorylation in experimental bilirubin encephalopathy.
    Diamond I; Schmid R
    Science; 1967 Mar; 155(3767):1288-9. PubMed ID: 6018655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin.
    Kaplan M; Hammerman C
    Clin Chim Acta; 2005 Jun; 356(1-2):9-21. PubMed ID: 15936300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental hemolysis model to study bilirubin encephalopathy in rat brain.
    Mejia GB; Sanz CR; Avila MM; Peraza AV; Guzmán DC; Olguín HJ; Ramírez AM; Cruz EG
    J Neurosci Methods; 2008 Feb; 168(1):35-41. PubMed ID: 17949822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA channel antagonist MK-801 does not protect against bilirubin neurotoxicity.
    Shapiro SM; Sombati S; Geiger A; Rice AC
    Neonatology; 2007; 92(4):248-57. PubMed ID: 17556843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative aspects of osmotic opening of the blood-brain barrier in experimental hyperbilirubinemia].
    Domínguez Ortega F; Martín Zarza M; Ormazábal Ramos JC; Rodríguez Luis JC; Doménech Martínez E
    An Esp Pediatr; 1993 Dec; 39(6):493-7. PubMed ID: 8166402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.
    Smith DL; Shire NJ; Watts NB; Schmitter T; Szabo G; Zucker SD
    J Clin Densitom; 2006; 9(1):105-13. PubMed ID: 16731439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects of bilirubinemia].
    Bonsi R; Bianco C; Papotti G
    Arch Sci Med (Torino); 1967 Aug; 124(2):196-207. PubMed ID: 17338106
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the remote sequels of neonatal hyperbilirubinemia].
    Paci A; Bartalena R; Di Bartolo F; Servi S
    Riv Neurobiol; 1968; 14(3):464-8. PubMed ID: 5714112
    [No Abstract]   [Full Text] [Related]  

  • 11. Auditory brainstem response detects early bilirubin neurotoxicity at low indirect bilirubin values.
    Smith CM; Barnes GP; Jacobson CA; Oelberg DG
    J Perinatol; 2004 Nov; 24(11):730-2. PubMed ID: 15510103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retinopathy in experimental amyotrophic leukospongiosis].
    Kolomiets ND; Votiakov VI; Kolomiets AG
    Dokl Akad Nauk SSSR; 1985; 285(6):1461-3. PubMed ID: 4092589
    [No Abstract]   [Full Text] [Related]  

  • 13. The risk of bilirubin encephalopathy in neonatal hyperbilirubinemia.
    Oktay R; Satar M; Atici A
    Turk J Pediatr; 1996; 38(2):199-204. PubMed ID: 8701485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats.
    Geiger AS; Rice AC; Shapiro SM
    Neonatology; 2007; 92(4):219-26. PubMed ID: 17556840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and preventing severe neonatal hyperbilirubinemia: is bilirubin neurotoxity really a concern in the developed world?
    Kaplan M; Hammerman C
    Clin Perinatol; 2004 Sep; 31(3):555-75, x. PubMed ID: 15325538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypercapnia induced reversible opening of the blood-brain barrier in experimental hyperbilirubinemia].
    Domínguez Ortega F; González Azpeitia G; Cidrás Pidre M; Calvo Rosales J
    An Esp Pediatr; 1997 Apr; 46(4):374-7. PubMed ID: 9214231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anoxia as a pathogenetic factor in experimental nuclear jaundice].
    Bondi R; Dini S; Gori G; Zalla PG
    Arch De Vecchi Anat Patol; 1966 Apr; 47(1):81-95. PubMed ID: 6011593
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bilirubin encephalopathy--bilirubin metabolism and Gunn rat as an experimental model].
    Kashiwamata S; Katoh-Semba R; Sato H
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1679-94. PubMed ID: 6398462
    [No Abstract]   [Full Text] [Related]  

  • 19. No association between hyperbilirubinemia and attention-deficit disorder.
    Kuzniewicz M; Escobar GJ; Newman TB
    Pediatrics; 2009 Feb; 123(2):e367-8. PubMed ID: 19171601
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperbilirubinemia: a risk factor for infection in the surgical intensive care unit.
    Field E; Horst HM; Rubinfeld IS; Copeland CF; Waheed U; Jordan J; Barry A; Brandt MM
    Am J Surg; 2008 Mar; 195(3):304-6; discussion 306-7. PubMed ID: 18206848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.